BUY AJANTAPHRMA IN DIPS NOW 1560.30 SL 1427 TARGET 1700
Over the last 5 years, revenue has grown at a yearly rate of 12.45%, vs industry avg of 6.95%
Over the last 5 years, market share increased from 0.95% to 1.22%
Over the last 5 years, net income has grown at a yearly rate of 8.58%, vs industry avg of 2.42%
Over the last 5 years, revenue has grown at a yearly rate of 12.45%, vs industry avg of 6.95%
Over the last 5 years, market share increased from 0.95% to 1.22%
Over the last 5 years, net income has grown at a yearly rate of 8.58%, vs industry avg of 2.42%
ملاحظة
HIGH 1646
إخلاء المسؤولية
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
إخلاء المسؤولية
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.